Company Filing History:
3 out of 27 
3 out of 12 
3 out of 10 
Years Active: 2020-2024
Title: Innovations and Contributions of Markus Kristofer Dahlgren
Introduction
Markus Kristofer Dahlgren is a notable inventor based in Shelton, CT (US). He has made significant contributions to the field of biochemistry and pharmacology, holding a total of 8 patents. His work primarily focuses on developing inhibitors that have potential therapeutic applications in various diseases.
Latest Patents
Dahlgren's latest patents include innovative compounds such as aryl-bipyridine amine derivatives, which serve as phosphatidylinositol phosphate kinase inhibitors. This invention is particularly relevant for treating cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases. Another significant patent involves pyrazolo[3,4-b]pyrazine derivatives that act as SHP2 phosphatase inhibitors. These compounds are crucial in regulating cellular biological activities through intracellular signaling processes initiated by extracellular signals.
Career Highlights
Throughout his career, Markus Kristofer Dahlgren has worked with prominent companies in the biotechnology sector, including D.E. Shaw Research, LLC and Relay Therapeutics, Inc. His expertise in the field has allowed him to contribute to groundbreaking research and development projects.
Collaborations
Dahlgren has collaborated with esteemed colleagues such as Sathesh P Bhat and Edward A Kesicki, further enhancing the impact of his work in the scientific community.
Conclusion
Markus Kristofer Dahlgren's innovative contributions and patents reflect his dedication to advancing medical science and improving therapeutic options for various diseases. His work continues to inspire future research and development in the field.